jsharpe

About Jenny Sharpe

This author has not yet filled in any details.
So far Jenny Sharpe has created 186 blog entries.

CIRS RD Briefing 69: Review of HTA outcomes and timelines 2014-2017

Timely recommendation for drug reimbursement by health technology assessment (HTA) agencies is critical to ensure that patient access to medicines of therapeutic value is not delayed. As part of [...]

2021-01-22T11:58:11+00:00August 11th, 2018|Tags: |

CIRS RD Briefing 68: Regulatory and HTA decision making and access to medicines – the consequences of sequence

Historically, every jurisdiction with some form of regulatory agency capacity has undertaken the review of medicines as a first step in the market access process. This step is intended [...]

2021-01-22T11:57:58+00:00August 1st, 2018|Tags: , , |

Wang et al 2018 – Building Synergy between Regulatory and HTA Agencies

Objectives: To evaluate the current practice of companies and agencies to assess the changes made in aligning regulatory and health technology assessment (HTA) stakeholders; to identify areas of commonality [...]

2021-01-18T17:02:46+00:00July 22nd, 2018|Tags: , , |

CIRS RD Briefing 67 – New approvals in six regulatory authorities 2008-2017

Major improvements in the regulatory environment as well as changes in strategies of multinational companies have led to a decrease in the time to marketing authorisation as well as [...]

2021-01-22T12:09:19+00:00May 4th, 2018|Tags: |

CIRS RD Briefing 65 – New approvals in six regulatory authorities 2007-2016

Over the last decade, 2007-2016, convergence in approval times as well as changes in strategies of multinational pharmaceutical companies have resulted in more new active substances (NASs) being internationalised, [...]

2021-01-22T13:35:36+00:00November 20th, 2017|Tags: |

Quality decision-making practices

This book compiles the presentations and syndicate discussions from a CIRS workshop that brought together representatives from international pharmaceutical companiesand regulatory authorities from Europe, US, Canada and Australia and [...]

2023-09-20T09:02:59+00:00November 19th, 2017|Tags: |

CIRS RD Briefing 64: Review of HTA outcomes and timelines 2014-2015

Timely recommendation for drug reimbursement by health technology assessment (HTA) agencies is critical to ensure patient access to medicines of therapeutic value. As part of an ongoing study to [...]

2025-03-20T16:47:50+00:00October 1st, 2017|Tags: , |
Go to Top